Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Diseases
4.2.2 Rising Pharmaceutical & Biopharmaceutical Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Cartridge Filter
5.1.2 Capsule Filter
5.1.3 Syringe Filter
5.1.4 Membrane
5.1.5 Accessories
5.2 By End User
5.2.1 Pharmaceutical & Biopharmaceutical Companies
5.2.2 Contract Research Organization
5.2.3 Research Laboratories
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Cole-Parmer Instrument Company, LLC
6.1.3 Danaher Corporation
6.1.4 Eaton Corporation
6.1.5 GE Healthcare
6.1.6 Merck KGaA
6.1.7 Sartorius AG
6.1.8 Porvair Filtration Group
6.1.9 Sterlitech Corporation
6.1.10 ThermoFisher Scientific Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS